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The fusion (F) protein of the paramyxovirus SV5 strain W3A causes syncytium formation without coexpression of the SV5
hemagglutinin-neuraminidase (HN) glycoprotein, whereas the F protein of the SV5 strain WR requires coexpression of HN for
fusion activity. SV5 strains W3A and WR differ by three amino acid residues at positions 22, 443, and 516. The W3A F protein
residues P22, S443, and V516 were changed to amino acids found in the WR F protein (L22, P443, and A516, respectively).
Three single-mutants, three double-mutants, and the triple-mutant were constructed, expressed, and assayed for fusion
using three different assays. Mutant P22L did not cause fusion under physiological conditions, but fusion was activated at
elevated temperatures. Compared with the W3A F protein, mutant S443P enhanced the fusion kinetics with a faster rate and
greater extent, and had a lower activation temperature. Mutant V516A had little effect on F protein-mediated fusion. The
double-mutant P22L,S443P was capable of causing fusion, suggesting that the two mutations have opposing effects on
fusion activation. The WR F protein requires coexpression of HN to cause fusion at 37°C, and does not cause fusion at 37°C
when coexpressed with influenza virus hemagglutinin (HA); however, at elevated temperatures coexpression of WR F protein
with HA resulted in fusion activation. In the crystal structure of the core trimer of the SV5 F protein (Baker, K. A., Dutch, R. E.,
Lamb, R.A., and Jardetzky, T. S. (1999). Mol. Cell 3, 309–319), S443 is the last residue (with interpretable electron density) in
an extended chain region and the temperature factor for S443 is high, suggesting conformational flexibility at this point. Thus,
the presence of prolines at residues 22 and 443 may destabilize the F protein and thereby decrease the energy required to
trigger the presumptive conformational change to the fusion-active state. © 2000 Academic Press
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CINTRODUCTION
Simian virus 5 (SV5) is a member of the Paramyxoviri-
dae family of viruses. SV5 encodes three integral mem-
brane glycoproteins, the hemagglutinin-neuraminidase
(HN), the fusion protein (F), and the small hydrophobic
protein (SH) (Hiebert et al., 1985a,b; Paterson et al.,
1984a,b), each of which is a component of the SV5 virion
envelope (He et al., 1998; Scheid et al., 1972; Scheid and
Choppin, 1974). The HN protein functions to attach the
virion to sialic acid, the viral receptor, on the surface of
target cells. The F protein is directly involved in virus-
mediated membrane fusion, which occurs at neutral pH.
The function of the SH protein is unknown. However, the
SH protein is not essential for replication of SV5 in
tissue-culture cells (He et al., 1998).
The F protein is synthesized as a precursor (F0) which
as to be proteolytically cleaved to generate the biolog-
cally active form of the protein, which consists of the
isulfide-linked subunits F1 and F2 (Homma and Ohuchi,
1973; Scheid and Choppin, 1974). At the newly generated
1 To whom correspondence and reprint requests should be ad-
ressed at Northwestern University, Department of Biochemistry, Mo-ecular Biology, and Cell Biology, 2153 North Campus Drive, Evanston,
L 60208-3500. Fax: (847) 491-2467. E-mail: ralamb@nwu.edu.
17N-terminus of the membrane-bound subunit F1 is a hy-
drophobic region known as the fusion peptide. The F
protein is a homotrimer (Russell et al., 1994) but little is
known concerning the atomic structure of the native F
protein. However, the atomic structure of a core fragment
of the SV5 F1 subunit (heptad repeat containing peptides
-1 and C-1) (Joshi et al., 1998) was determined recently
at 1.4-Å resolution (Baker et al., 1999). An N-terminal
central coiled-coil, which is linked to the fusion peptide,
is surrounded by three C-terminal antiparallel helices.
This core structure is thought to represent the final most
stable form of the protein either at fusion or after fusion
has occurred, and it is structurally related to the core
structure of other viral-fusion proteins such as the low
pH-induced form of the HA2 subunit of influenza A virus
emagglutinin (HA), gp41 of human immunodeficiency
irus, env-TM domain protein of Moloney murine leuke-
ia virus, and GP2 of Ebola virus (Bullough et al., 1994;
han et al., 1997; Fass et al., 1996; Weissenhorn et al.,
1998).
For most paramyxoviruses the available evidence sug-
gests that coexpression of the homotypic HN is required
for F-mediated membrane fusion to occur (Cattaneo and
Rose, 1993; Deng et al., 1995; Ebata et al., 1991; Horvath
et al., 1992; Hu et al., 1992; Morrison et al., 1991; Stone-
Hulslander and Morrison, 1999; Tanabayashi et al., 1992;
0042-6822/00 $35.00
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18 PATERSON, RUSSELL, AND LAMBTong and Compans, 1999; Wild et al., 1991). However, for
the W3A strain of SV5 the F protein can promote fusion in
the absence of the homotypic HN and can promote
syncytia formation in cell monolayers in the absence of
any viral binding protein (Dutch et al., 1998; Horvath and
Lamb, 1992; Horvath et al., 1992; Ito et al., 1997; Paterson
t al., 1985; Ward et al., 1995). Recently, the fusion re-
uirements of another strain of SV5, WR, were examined
nd compared with those of the W3A strain (Ito et al.,
997). It was found that when the WR F protein was
xpressed in BHK cells, syncytia formation was depen-
ent on the coexpression of SV5 HN (derived from W3A
r WR strains), and unexpectedly the mumps virus HN
ould substitute for the SV5 HN protein (Ito et al., 1997).
comparison of the amino acid sequences of the W3A
nd WR F proteins indicates that only the three residues
2, 443, and 516 differed between the two sequences
Fig. 1) (Ito et al., 1997; Paterson et al., 1984b). Single
mino acid substitutions were made in the WR cDNA
ith residues found in the analogous position in the W3A
protein; i.e., leucine at position 22 to proline, proline at
osition 443 to serine, and alanine at position 516 to
aline (Ito et al., 1997). When the mutant proteins were
xpressed in tissue culture, with and without HN, it was
ound that substituting the leucine at position 22 with
roline in the WR F protein resulted in an F protein that
ow could cause syncytia formation in the absence of
N (Ito et al., 1997). Apparently, a single amino acid
ubstitution converted the F protein from an HN-depen-
ent to an HN-independent fusion protein.
We have examined the interplay of residues 22, 443,
nd 516 of the SV5 F protein in mediating membrane
usion in more detail using single and double amino acid
FIG. 1. Schematic diagram of the W3A F protein. The positions of t
transmembrane domain, and cytoplasmic tail are shown. The three am
are also indicated with the single-letter code for the W3A residue show
the number.ubstitutions in the W3A F protein and by using sensitive
nd quantitative fusion assays. The data obtained arenterpreted as being relevant to understanding the tran-
ition of the F protein from a presumptive metastable
onformation to a more stable conformation, a transition
hat occurs during the membrane-fusion event.
RESULTS
xpression of the wt and mutant F proteins
The F proteins of the SV5 W3A and WR strains differ by
hree amino acid residues at positions 22, 443, and 516
Ito et al., 1997). In Fig. 1 the positions of these residues
are shown in relation to the biologically important struc-
tural features of the SV5 F protein: the N-terminal signal
sequence, the cleavage site, the fusion peptide, heptad
repeats A and B (N-1 and C-1) that assemble into the
core trimer (Joshi et al., 1998), the transmembrane do-
main, and the cytoplasmic tail.
The W3A F gene was subjected to site-specific mu-
tagenesis such that amino acid residues P22, S443, and
V516 were replaced with the amino acids found in the
WR F protein (L22, P443, and A516, respectively).
Each residue was changed individually to yield the
single-mutant F proteins P22L, S443P, and V516A.
The single mutations were then combined to make the
three double-mutants—P22L,S443P; P22L,V516A; and
S443P,V516A—and the triple-mutant P22L,S443P,V516A.
The amino acid sequence of the W3A triple-mutant F
protein is identical to that of the WR F protein and thus,
for simplicity, it is referred to as WR. To examine the
cell-surface expression of the mutant F proteins relative
to that of the W3A F protein, the proteins were expressed
transiently in CV-1 cells using the recombinant vaccinia
virus-T7 RNA polymerase system (vac-T7) (Fuerst et al.,
al sequence, cleavage site, fusion peptide, heptad repeats A and B,
id residues that are not conserved between the W3A and WR strains
eding the residue number and the code for the WR residues followinghe sign
ino ac1986) and the cells were stained for flow cytometry using
the F-specific monoclonal antibody (MAb) F1a (Randall et
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19PARAMYXOVIRUS FUSION ACTIVATION MUTANTSal., 1987). As shown in Table 1 the mutant F proteins
were expressed at the cell surface to levels of at least
76% of that of the W3A F protein.
F protein-mediated cell–cell fusion
To analyze in detail the effect of the mutations on the
fusion activity of the W3A F protein, the ability of the
mutant proteins to mediate the mixing of the outer leaf-
lets of the plasma membrane, often referred to as lipid
mixing, was examined. In addition, the ability of the
mutant proteins to permit the mixing of the aqueous
cytoplasmic contents between two cells was measured.
Although the W3A F protein can induce syncytia forma-
tion when expressed by itself in monolayers of CV-1 and
BHK cells (Horvath et al., 1992; Ito et al., 1997; Paterson
et al., 1985), the assays used here to examine lipid
mixing and aqueous content mixing involve the binding
together of two cell populations, and this requires the
coexpression of the F protein and a sialic acid binding
protein.
Analysis of lipid mixing by confocal microscopy. The
mixing of the outer leaflets of the plasma membrane can
be measured by the transfer of the lipophilic dye R18
from the membrane of labeled human erythrocytes
(RBCs) to the membrane of F protein-expressing accep-
tor CV-1 cells. The W3A and mutant F proteins were
coexpressed with the SV5 W3A HN protein in CV-1 cells
using the vac-T7 expression system, and fusion assays
were performed with RBC-cell complexes and the cells
examined by confocal microscopy. As shown previously
for the W3A F protein (Bagai and Lamb, 1995b; Dutch et
al., 1998), fusion of the RBCs with CV-1 cells was not
TABLE 1
Cell-Surface Expression of Mutant F Proteins
F protein expressed
Relative
expressiona
Relative mean
fluorescence
intensity
3A 1.00 1.00
22L 1.02 0.76 6 0.04
443P 1.07 1.08 6 0.07
516A 1.07 1.05 6 0.02
22L,S443P 1.01 0.90 6 0.03
22L,V516A 0.99 1.00 6 0.01
443P,V516A 1.07 1.02 6 0.04
R (P22L,S443P,V516A) 1.05 0.90 6 0.03
Note. F proteins were expressed in CV-1 cells using the vac-T7
xpression system. Surface expression of the F protein was deter-
ined by flow cytometry using the Fla MAb (Randall et al., 1987)
ollowed by fluorescein isothiocyanate-conjugated secondary antibody
n 5 2).
a Number of cells expressing F normalized to W3A: transfection
fficiency for W3A was 80–90%, depending on the experiment.observed without a period of incubation at 37°C (Fig. 2;
compare W3A 4°C to W3A 37°C). Expression of mutantP22L caused no lipid mixing (Fig. 2). This result was
unexpected given that the WR F protein, which has a
leucine at position 22, can cause membrane fusion (Ito et
al., 1997) as measured by syncytia formation when co-
expressed with HN of the W3A or WR strains. In contrast,
expression of mutant S443P induced more extensive
lipid mixing than did expression of the W3A F protein
(Fig. 2). The double-mutant P22L,S443P exhibited limited
fusion activity as measured by R18 transfer (Fig. 2). The
R18 transfer activity of the mutant V516A was similar to
that of W3A F (data not shown) and the double-mutants
P22L,V516A and S443P,V516A exhibited lipid-mixing ac-
tivity that was indistinguishable from those of the single
mutants P22L and S443P, respectively (data not shown).
The WR F protein appeared to exhibit less lipid-mixing
activity than that of the W3A F protein (Fig. 2).
It has been shown previously that the W3A F protein
can induce lipid mixing when influenza virus HA, rather
than the homotypic HN protein, is used as the sialic acid
binding protein (Bagai and Lamb, 1995a). Therefore, it
was of interest to determine whether HA could substitute
for HN when coexpressed with the mutant F proteins.
Lipid-mixing assays were performed as described earlier
using CV-1 cells coexpressing either the W3A or mutant
F proteins and HA as the binding protein. As shown in
Fig. 3, for most of the mutant proteins, coexpression of F
and HA gave results similar to those obtained when the
F proteins were coexpressed with HN. For example, R18
transfer observed for mutant V516A was similar to that
seen with W3A F (Fig. 3, V516A), mutants S443P and
S443P,V516A caused more extensive dye transfer than
W3A (compare panels in Fig. 3), and there was no de-
tectable R18 transfer observed with mutants P22L and
P22L,V516A (Fig. 3). The exceptions were the double-
mutant P22L,S443P and WR F, where coexpression with
HN resulted in limited lipid mixing, whereas on coex-
pression with HA detectable R18 transfer was not ob-
served (compare Figs. 2 and 3). Expression of influenza
virus HA in CV-1 cells did not induce lipid mixing at
neutral pH (Fig. 3, HA alone).
Spectrofluorimetric analysis of lipid mixing. The results
obtained by using the confocal microscope to monitor
lipid mixing indicated that the S443P mutant F protein
was able to promote lipid mixing more extensively than
was the W3A F protein. To determine whether S443P
induced lipid mixing at an increased rate and to a greater
extent than fusion induced by the W3A F protein, spec-
trofluorimetric analysis of lipid mixing was undertaken.
For these experiments W3A and S443P F proteins were
coexpressed with influenza virus HA because, unlike
SV5 HN, it does not possess neuraminidase activity, an
activity which can lead to rapid elution of the erythro-
cytes when the cells are in suspension. As shown in Fig.
4 the S443P mutant F protein induced fusion that had an
increased initial rate and greater final extent than fusion
induced by the W3A F protein.
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20 PATERSON, RUSSELL, AND LAMBAnalysis of content mixing. To examine the aqueous
content mixing resulting from membrane fusion medi-
ated by the W3A and mutant F proteins, a sensitive and
quantitative reporter assay was used (He et al., 1998). In
this assay monolayers of Vero cells are transfected with
plasmids expressing the F and HN genes under the
control of the chicken b-actin promoter (pCAGGS) (Niwa
t al., 1991) and a plasmid containing the chloramphen-
col acetyl transferase (CAT) gene under the control of
he T7 RNA polymerase promoter. A separate population
f Vero cells was transfected with a plasmid containing
he T7 RNA polymerase gene under the control of the
hicken b-actin promoter. After overnight incubation to
allow expression of the F, HN, and T7 RNA polymerase
proteins, the T7 RNA polymerase-expressing cells were
overlaid onto the F- and HN-expressing cells. Expression
of the CAT protein was obtained on fusion and mixing of
the cytoplasms of the two cell populations. The data of a
typical experiment, performed in duplicate, are shown in
Fig. 5. As observed in the lipid-mixing assay, mutants
P22L and P22L,V516A were barely above background
levels and the addition of the S443P mutation to the P22L
protein restored some fusion activity (P22L,S443P). In
addition, in agreement with the R18 outer-leaflet fusion
FIG. 2. Lipid-mixing activity of the W3A and mutant F proteins when
ells coexpressing HN and either W3A F or selected F mutant proteins
onfocal microscopy as described in Materials and Methods. W3A F
ncubated at 37°C for 10 min.assay, the F mutant proteins S443P and S443P,V516A
cause increased cytoplasmic content mixing comparedwith that caused by W3A (Fig. 5). Interestingly, in this
assay the cytoplasmic tail mutant V516A was also capa-
ble of causing greater content mixing than was W3A,
whereas when lipid mixing was measured the results
obtained for the two proteins were similar (Figs. 2 and 5).
Syncytium formation. The ability of the W3A F protein
to induce syncytia when expressed in mammalian cell
monolayers in the absence of HN is well documented
(Horvath et al., 1992; Ito et al., 1997; Paterson et al., 1985).
As the F mutant proteins were found to differ according
to the efficiency with which they could cause lipid or
content mixing, in a relatively short timescale, it was of
interest to compare their syncytia-forming activity, which
occurs over a longer timescale. However, the extensive
nature of SV5 F protein-induced syncytia makes quanti-
fication cumbersome. For syncytia assays subconfluent
monolayers of BHK 21F cells were cotransfected with
pCAGGS plasmids expressing F and HN, or F and HA, or
transfected with pCAGGS F alone. The syncytia pro-
duced in BHK 21F cells when the F proteins were coex-
pressed with HN is shown in Fig. 6A. Untransfected or
HN-expressing BHK cells show some small areas of
spontaneous fusion where three to six cells form a giant
cell (data not shown) and such giant cells can be ob-
ssed with the SV5 HN protein. R18-labeled RBCs were bound to CV-1
. Fusion was initiated by incubation at 37°C. Fusion was detected by
(no incubation at 37°C). The samples in the remaining panels werecoexpre
at 4°Cserved for F mutants P22L and P22L,V516A. These two
mutants did not cause any syncytia formation over the
o Fig. 2
icrosc
21PARAMYXOVIRUS FUSION ACTIVATION MUTANTSlevel of spontaneous fusion. All the other F proteins
tested induced the formation of syncytia in BHK 21F
when coexpressed with HN.
Although difficult to represent in the photomicrographs
shown in Fig. 6A, because of the inherent conflict of
showing individual cells versus the entire 6-cm-diameter
monolayer of cells, the extent and size of the syncytia
observed were consistent with the results of the R18
assay for lipid mixing. Expression of the S443P-contain-
ing mutants induced the most extensive areas of syncy-
tia, W3A F and V516A induced less-extensive areas of
syncytia formation, and double-mutant P22L,S443P and
FIG. 3. Lipid-mixing activity of the W3A and mutant F proteins wh
performed as described under Materials and Methods and the legend t
All the samples were incubated at 37°C for 10 min prior to confocal mWR F induced syncytia that were more limited in size.
When HA protein was cotransfected with the F proteins,WR F and P22L,S443P were unable to cause syncytia
formation; otherwise, the data were similar to those ob-
tained upon cotransfection of F and HN, with mutant
V516A inducing syncytia similar in size to those of W3A F
protein and mutants S443P and S443P,V516A inducing
more extensive syncytia. The data for W3A, WR, S443P,
and P22L are shown in Fig. 6B. Finally, all the F proteins
were tested for their ability to cause cell fusion when
expressed alone in BHK 21F cells. The data for W3A and
mutant S443P are shown in Fig. 6B (bottom panel) and it
can be seen that there are extensive areas of syncytia
formation. It was found that F proteins containing a
xpressed with the influenza HA protein. The lipid-mixing assay was
. HA alone (uncleaved HA expressed alone and no low pH activation).
opy.en coeleucine at position 22 (WR; P22L; P22L,S443P;
P22L,V516A) were unable to promote syncytia formation
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22 PATERSON, RUSSELL, AND LAMBwhen expressed alone, expression of mutant V516A re-
sulted in syncytia similar in size to those observed for
W3A, and S443P,V516A gave rise to syncytia that were
similar in size to those seen with S443P (data not
shown).
Temperature dependence of fusion of mutants S443P
and P22L as compared with that of W3A F protein
and dependence of HA requirement of WR F protein
It seemed possible that the difference in phenotype
between mutants S443P and P22L may be the result of a
difference in energy required for fusion activation; there-
fore, the effect of temperature on the fusion activity of the
W3A, S443P, and P22L F proteins were compared. Hu-
man RBCs were double-labeled with the lipid probe R18
and the aqueous cytoplasmic probe 6-carboxyfluores-
cein (CF) and bound to CV-1 cells coexpressing HN and
either W3A, S443P, or P22L mutant F proteins. After
washing away unbound RBCs, the F- and HN-expressing
cells were incubated for 10 min at various temperatures
and returned to ice, and the lipid and aqueous dye
transfer visualized using a confocal microscope.
As shown in Fig. 7A, incubation at 37°C resulted in
R18 transfer similar to that shown in Fig. 2 for W3A and
S443P F proteins with the S443P protein, causing more
extensive lipid mixing than that caused by W3A F protein.
The CF aqueous dye transfer for the same fields of cells
indicated that S443P was also more efficient than W3A F
protein at promoting content mixing (Fig. 7A), as shown
earlier using the CAT assay for content mixing. When the
FIG. 4. Kinetics of R18 fluorescence dequenching. R18-labeled RBCs
were bound to CV-1 cells coexpressing either W3A F or S443P and
influenza HA, and the cell complexes were prepared for spectrofluori-
metric analysis as described under Materials and Methods. The traces
shown are the results of a typical experiment.temperature of incubation was lowered to 29°C a dra-
matic decrease in the fusion (both lipid mixing and con-
atent mixing) mediated by the W3A F protein was ob-
served, whereas the activity of the S443P F protein was
unchanged. Lowering the temperature further to 22°C
had very little effect on the fusion activity of S443P,
whereas W3A F protein-mediated fusion was completely
inhibited. At 18°C there was a reduction in both the lipid
mixing and content mixing mediated by S443P (data not
shown) and at 15°C, S443P fusion was completely inhib-
ited (Fig. 7A). It is also important to note for both W3A and
S443P F proteins that the number of cells simultaneously
undergoing lipid and aqueous mixing is similar (compare
R18 and CF panels, Fig. 7A).
Mutant P22L F protein had the opposite phenotype to
S443 P and caused fusion only at elevated temperatures.
Fusion of RBCs with CV-1 cells expressing P22L was not
detected at 37°C (Fig. 2). However, increasing the tem-
perature to 45°C triggered a limited amount of P22L-
mediated fusion (Fig. 7B). At 53°C somewhat more P22L-
mediated fusion was observed (data not shown). Inter-
estingly, for some cells only R18 transfer and not CF dye
mixing was observed, but at the present time we cannot
determine whether the data reflect fusion halted at the
hemifusion stage or whether the integrity of some CV-1
cell membranes has been breached at the higher tem-
FIG. 5. Content-mixing activity of the W3A and mutant F proteins.
Vero cells were cotransfected with plasmids encoding the F and HN
proteins under the control of the chicken b-actin promoter and the
lasmid encoding CAT under the control of the T7 RNA polymerase
romoter. A second set of Vero cells was transfected with the plasmid
ncoding T7 RNA polymerase under the control of the b-actin promoter.
fter overnight incubation the T7 RNA polymerase-expressing cells
ere overlaid onto the F- and HN-expressing cells containing the CAT
lasmid. F protein-mediated membrane fusion allows T7 RNA polymer-
se to gain access to the CAT plasmid, which results in CAT protein
xpression. The CAT activity was assayed as described under Material
nd Methods. No CAT 5 cells transfected with plasmids encoding HN
nd W3A F only. CAT activity is expressed as [14C] counts per minute;
n 5 2.
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23PARAMYXOVIRUS FUSION ACTIVATION MUTANTSperatures, causing the CF label to leach out. No R18 or
CF dye transfer was observed at 45°C when HN was
expressed without P22L (data not shown). The specificity
of the F protein-mediated fusion at 45°C was shown
further by the ability to block fusion upon addition of the
MAb F1a, an antibody shown previously to block fusion
(Bagai and Lamb, 1995b) (Fig. 7B).
The WR F protein would not cause fusion at 37°C
using HA as a binding protein (Fig. 3). Therefore, we also
tested whether increasing the temperature would trigger
WR F protein to cause fusion on coexpression with HA.
As shown in Fig. 7B, WR F protein did not cause fusion
with HA at 45°C but it did cause fusion when the tem-
perature was increased to 53°C. Similar to the results for
HN 1 P22L at 45°C, more cells showed lipid mixing than
ontent mixing. When HA (uncleaved, no low pH treat-
ent) was expressed alone, no lipid mixing was ob-
erved, and fusion was blocked by addition of the MAb
1a, indicating that the fusion observed was mediated by
he WR F protein (data not shown).
DISCUSSION
We have introduced mutations into the SV5 W3A F
rotein corresponding to the three amino acid residues
hat have been found to differ between the W3A and WR
trains of SV5 (Ito et al., 1997; Paterson et al., 1984b) and
ave analyzed in detail the effect the mutations have on
he fusion activity of the W3A F protein. As shown in Fig.
the residues that differ between the two strains are
ocated at residue 22, residue 443, and residue 516. By
sing various sensitive assays for membrane fusion, we
ave examined the relative ability to promote fusion of
roteins that possess single mutations, the three possi-
le combinations of double mutations, and the triple-
utant, which is equivalent to the WR F protein. All the
utant F proteins were expressed at the cell surface and
ere recognized by a conformation-specific monoclonal
ntibody. Thus, gross changes to F protein folding are
nlikely, but the possibility cannot be eliminated that
ocalized conformational differences exist.
The experiments of Ito and colleagues (1997) were
onfirmed by finding that a proline at residue 22 is
mportant in defining the HN-independent fusion activity
f the W3A F protein. However, in the converse experi-
ent when we substituted proline at position 22 in the
3A F protein with leucine, the resulting F protein was
o severely debilitated for fusion that we were unable to
etect fusion even in the presence of HN (Figs. 2, 5, and
). Another striking result was obtained on making the
443P substitution in the W3A F protein. The S443P
utant was found to have greater fusion-promoting ac-
ivity than that of W3A F in every assay used (Figs. 2–7),
nd spectrofluorimetric measurement of the lipid mixingnduced by the W3A and S443P F proteins showed that
443P had both a faster initial rate and greater final
r
txtent of lipid mixing than did W3A F protein (Fig. 4).
ombining the P22L and S443P substitutions in the dou-
le-mutant P22L,S443P gave rise to a protein that had
imited fusion-promoting activity when coexpressed with
N (Figs. 2, 5, and 6), showing that the negative effect of
eucine at position 22 can be compensated for, to some
xtent, by the fusion-enhancing effect of proline at posi-
ion 443. The opposing effects of these two residues are
resumably the reason that the WR fusion protein is less
ctive than the W3A F protein in some assays for fusion
e.g., Figs. 2 and 6A). The V516A mutant F protein had
ittle effect on fusion, except in the CAT assay for cyto-
olic content mixing, when a reproducibly higher level of
ctivity was observed. We do not know the reason for
his increased activity but clearly the cytoplasmic tail of
he F protein contributes to fusion activity (Bagai and
amb, 1996).
By analogy to influenza A virus HA, the SV5 F protein
s presumed to exist in a metastable native fusion-inac-
ive state in which the F1 N-terminal fusion peptide is
buried within the interior of the protein (Baker et al., 1999;
Lamb, 1993). It is predicted that the F protein will be
induced to undergo a conformational change, by an
as-yet unidentified trigger, in which the fusion peptide
will be exposed and the protein will undergo a confor-
mational change, which may include a refolding event, to
a fusion active form (Lamb, 1993). The experiment in
which the temperature dependence of F-mediated fusion
was tested (Fig. 7) suggests that the energy barrier for
the conformational change from the metastable state to
the fusion-active conformation is lower for the S443P
mutant than it is for the W3A F protein. Conversely, the
energy barrier for mutants containing P22L is much
higher than that for W3A F protein. Thus, these data are
consistent with the notion that the S443P and P22L
mutations in W3A F protein are compensating changes
and that the residues at these locations in the protein
play a key role in the transition to the fusion-active form.
These data also emphasize the role of the HN protein in
triggering the fusion reaction. In syncytia assays coex-
pression of the SV5 HN protein augments the extent of
syncytia formation by W3A F protein expressed alone
(Horvath et al., 1992). In content-mixing assays, when HN
s used as a binding protein W3A F protein-mediated
usion occurs to a greater extent than when HA is used
s a binding protein (Paterson, Russell, and Lamb, un-
ublished observations). Furthermore, WR F protein
oes not cause fusion at 37°C when using HA as the
inding protein (Fig. 3); however, when the temperature
as raised to 53°C fusion occurred, suggesting that the
N function for WR F protein triggering can be artificially
upplanted by providing energy from raising the temper-
ture. A direct protein–protein interaction between F and
N and a conformational change in HN on binding itseceptor sialic acid could provide the energy to trigger
he F protein under natural conditions.
24 PATERSON, RUSSELL, AND LAMBFIG. 6. Syncytia assay. Monolayers of BHK 21F cells were transfected with plasmids encoding F and HN, F and HA, or F alone as described under
Materials and Methods. At 18 to 24 h posttransfection, monolayers were examined for the presence of syncytia. Representative photomicrographs
are shown. (A) F and HN; (B) F and HA and F alone.
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25PARAMYXOVIRUS FUSION ACTIVATION MUTANTSIn some respects the P22L and S443P mutants are
related conceptually to mutants in the influenza virus HA
protein that were selected for their ability to grow in the
presence of amantadine hydrochloride (Daniels et al.,
1985). The HA mutants were found to undergo the pH-
dependent conformational change at a pH higher than
that of the wt HA. Many of the amino acid substitutions
that were identified in the mutant HA proteins were
FIG. 6recognized as changes that would be likely to destabilize
the pH 7 conformation, thus reducing the energy barrier tto the low pH-induced conformational change (Daniels et
al., 1985).
We have shown previously that the peptide N-1 (F
residues 122–184) corresponding to the heptad repeat
that abuts the fusion peptide and the peptide C-1 (F
residues 435–477), which includes the heptad repeat B
that abuts the transmembrane domain, form a highly
stable complex which is a trimer of heterodimers (Dutch
nuedet al., 1999; Joshi et al., 1998). In the crystal structure of
his F1 core trimer two copies of the N1/C1 heterodimer
ion is in
26 PATERSON, RUSSELL, AND LAMBare observed in the crystallographic asymmetric unit and
for one copy the interpretable electron density ends with
FIG. 7. Temperature dependence of W3A, S443P, and P22L F prote
fusion with HA. Human RBCs double-labeled with the lipid probe R18 an
the W3A, mutant S443P, or mutant P22L F proteins, or were bound to
10 min at different temperatures and examined for both lipid mixing and
are shown for the same field of cells. (A) W3A and S443P F protein-me
WR F protein-mediated fusion. Temperature of incubation to trigger fus
prior to adding the dual-labeled RBCs and raising the temperature.S443, whereas in the other copy electron density can be
interpreted to Q440 (Baker et al., 1999). S443 is situatedin the extended chain region of the C-1 peptide and it is
beyond the conserved L447 and I449 residues that make
iated fusion, and temperature dependence of WR F protein-mediated
ueous probe CF were bound to CV-1 cells coexpressing HN and either
ells coexpressing HA and WR F protein. The cells were incubated for
nt mixing by confocal microscopy. The lipid mixing and content mixing
fusion. (B) P22L F protein-mediated fusion, and HA coexpressed with
dicated. F1a 5 addition of a 1:100 dilution of ascites fluid of MAb F1ain-med
d the aq
CV-1 c
conte
diatedhydrogen bonds with the conserved Q169 and N173
residues of the N-1 coiled-coil. The temperature factor of
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27PARAMYXOVIRUS FUSION ACTIVATION MUTANTSS443 is high, suggesting conformational flexibility in the
structure at this point and it has been suggested that F
protein residues between the last residue of N-1 (residue
184) and the beginning of the C-1 peptide (residue 440/
443) constitute a separate domain of the F protein (Baker
et al., 1999). There is no information on the structure of
the F2 subunit that contains the P22L mutation. However,
ased on the data presented here on the importance of
he nature of residues 22 and 443 in biological activity we
ow speculate that the presence of proline at residues
2 and 443 destabilize the protein such that it is more
eadily triggered to undergo the conformational change
o the fusion-active state. Conversely, the presence of a
eucine residue at position 22 increases the stability of
he F protein such that fusion can be triggered only at
7°C if a proline is located at residue 443.
MATERIALS AND METHODS
ells and viruses
Monolayer cultures of Vero cells and the TC7 subclone
f CV-1 cells were grown in Dulbecco’s modified Eagle’s
edium (DMEM) supplemented with 10% fetal bovine
erum (FCS). BHK 21F monolayers were grown in DMEM
upplemented with 10% FCS and 10% tryptose phos-
FIG. 7hate broth. The recombinant vaccinia virus vTF7–3,
hich expresses bacteriophage T7 RNA polymerase,nd the wild-type vaccinia virus WR were grown in CV-1
ells as described previously (Fuerst et al., 1986).
lasmids
The SV5 F cDNA (Paterson et al., 1984a,b) was sub-
loned into pGem2X, a derivative of pGem2 contain-
ng an XhoI site. The genes encoding the F mutant
roteins were constructed by USE site-specific mutagen-
sis (Amersham Pharmacia Biotech Inc. Piscataway, NJ)
ccording to the manufacturer’s directions. The mutant F
enes were sequenced in their entirety using a BigDye
erminator cycle-sequencing ready-reaction kit (Perkin–
lmer Applied Biosystems [ABI], Foster City, CA) and a
BI 310 automated DNA sequencer. The SV5 HN cDNA
Hiebert et al., 1985a; Paterson et al., 1984b) was sub-
loned into pGem3X, a derivative of pGem3 containing
n XhoI site. Plasmid pTF7.5 HA, which contains the HA
DNA of influenza virus A/Udorn/72, was described pre-
iously (Simpson and Lamb, 1992) and pGINT7bgal (Dr.
Richard A. Morgan, National Center for Human Genome
Research) was kindly provided by Edward Berger and
Bernard Moss (National Institutes of Health, Bethesda,
MD). The cDNAs encoding the W3A F, F P22L mutant,
and HN proteins were subcloned into the XhoI site in
pCAGGS (Niwa et al., 1991). The Udorn HA cDNA was
nuedexcised from pTF7.5 by SacI digestion and subcloned
into pCAGGS/MCS (Niwa et al., 1991). The cDNAs en-
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28 PATERSON, RUSSELL, AND LAMBcoding the remaining F mutants were amplified by PCR
using a 59 primer containing an EcoRI site and a 39
primer containing a ClaI site and were subsequently
cloned into pCAGGS/MCS. Plasmid pBH82, which con-
tains the chloramphenicol acetyl transferase gene (CAT)
under the control of the T7 RNA polymerase promoter,
has been described previously (He et al., 1995). The
plasmid containing the T7 RNA polymerase gene was
prepared by excising the T7 RNA polymerase gene from
pYZ4 (Zhou et al., 1990) by digestion with StuI and BamHI
and subcloning it into pCAGGS digested with SmaI and
BglII.
Expression of F, HN, and HA proteins
For confocal microscopy and fluorimetry assays the F,
HN, and HA proteins were expressed using the recom-
binant vaccinia virus–T7 RNA polymerase transient ex-
pression system (Fuerst et al., 1986). Briefly, monolayer
cultures of CV-1 cells in 60- or 35-mm-diameter tissue-
culture dishes were infected with recombinant vTF7–3 at
10 plaque forming units (pfu) per cell and incubated at
37°C for 1 h. The cells were then transfected with 2.4 mg
of pGem F and 2.4 mg of pGem HN or HA plasmid DNA
made up to 5.0 mg DNA using empty vector DNA) in
Optimem (Life Technologies, Gaithersburg, MD) using
cationic liposomes prepared as described previously
(Rose et al., 1991). At 4 h posttransfection the monolayers
were washed with phosphate-buffered saline (PBS) and
incubated in DMEM supplemented with 10% FCS over-
night at 33°C. For syncytia assays the F, HN, and HA
proteins were transiently expressed using the pCAGGS
F, HN, and HA plasmids. Monolayer cultures of BHK 21F
cells in 60-mm tissue-culture dishes were transfected
with 2 mg of DNA using Lipofectamine Plus (Life Tech-
ologies) according to the manufacturer’s protocol. Syn-
ytia were examined at 18 to 24 h posttransfection using
Nikon Diaphot inverted phase-contrast microscope (Ni-
on Inc., Garden City, NY). Photographs were taken using
Kodak DCS 420 digital camera (Eastman Kodak Com-
any, Rochester, NY).
uantification of F protein cell-surface expression
Monolayers of CV-1 cells in 60-mm dishes infected
ith vTF7–3 and transfected as described earlier were
repared for flow cytometry as described previously
Horvath and Lamb, 1992). The monoclonal antibody F1a,
pecific for the SV5 F protein (Randall et al., 1987), was
sed as the primary antibody and fluorescein isothiocya-
ate-conjugated goat anti-mouse immunoglobulin G
Jackson Immunoresearch Laboratories Inc., West Grove,
A) as the secondary antibody. The cell-surface fluores-
ence of 10,000 cells was analyzed using a FACSCalibur
lowcytometer (Becton Dickinson, San Jose, CA).
d
(abeling of human erythrocytes with octadecyl
hodamine B chloride and 6-carboxyfluorescein
Freshly drawn human erythrocytes (RBCs) were la-
eled with the lipid probe octadecyl rhodamine B chlo-
ide (R18; Molecular Probes, Eugene, OR) as described
reviously (Bagai and Lamb, 1995b; Morris et al., 1989).
o prepare double-labeled RBCs, R18-labeled RBCs
ere loaded with 6-carboxyfluorescein (CF; Molecular
robes) as previously described (Melikyan et al., 1995).
Analysis of lipid and content mixing by scanning
confocal microscopy
Following overnight incubation at 33°C transfected
CV-1 cells grown on glass coverslips and expressing F
and HN or expressing F and HA were washed with PBS
and incubated for 1 h at 37°C with 50 mU per ml of
neuraminidase (Clostridium perfringens type V; Sigma
Chemical Co., St. Louis, MO). The cells were then
washed twice with ice-cold PBS and incubated with 0.5
ml of R18-labeled RBCs (0.05% hematocrit) or 0.5 ml of
R18/CF double-labeled RBCs (0.25% hematocrit) at 4°C
for 30 min. Unbound RBCs were removed by washing
with ice-cold PBS, keeping the cells at 4°C until fusion
was initiated by incubation at the desired temperature.
After 10 min at 37°C, fusion was terminated by transfer-
ring the cells to ice, after which dye transfer was exam-
ined using a scanning confocal microscope (Zeiss LSM
410, Zeiss Instruments Inc., Thornwood, NY).
Spectrofluorimetric analysis of lipid mixing
To measure the kinetics of lipid mixing, F- and HA-
transfected CV-1 cells in 60-mm dishes were treated with
neuraminidase and washed with cold PBS as described
earlier. The R18-labeled RBCs were counted using a
hemocytometer and diluted. The CV-1 cells were incu-
bated with ;2 RBCs per CV-1 cell in a volume of 1.5 ml
at 4°C for 30 min. The unbound RBCs were removed by
washing with cold PBS and the RBC-cell complexes
were removed from the dishes by incubation at 4°C in
PBS (deficient in calcium and magnesium) containing 50
mM EDTA. The complexes were pelleted by centrifuging
at 400 g for 2 min and resuspended in 100 ml of PBS; 50
ml was added to 3 ml of prewarmed PBS to assay for lipid
mixing. The fluorescence was measured continuously
using a spectrofluorimeter (series 2; SLM Aminco-Bow-
man, Rochester, NY) with 1-s time resolution at excitation
and emission wavelengths of 560 and 590 nm, respec-
tively. To reduce scattering, a 570-nm cutoff filter was
placed in the emission optical pathway. The percentage
fluorescence dequenching (%FDQ) was calculated as
100(F 2 F0/F t 2 F0), where F0 and F are the fluorescence
t time zero and at a given time point and F t is the
luorescence intensity in the presence of 1% Triton X-100,
efined as the fluorescence at infinite dilution of the R18
Bagai et al., 1993; Sarkar et al., 1989).
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29PARAMYXOVIRUS FUSION ACTIVATION MUTANTSCAT assay for content mixing
The analysis of content mixing using a sensitive CAT
assay was performed essentially as described previ-
ously (He et al., 1998). Briefly, monolayers of Vero cells in
-well dishes were transfected with 0.8 mg each of
CAGGS F, pCAGGS HN or HA, and pBH82 (CAT) using
ipofectamine Plus according to the manufacturer’s in-
tructions. The negative control consisted of transfec-
ions in which the CAT plasmid was replaced with
CAGGS vector. Vero cells in 6-cm dishes were trans-
ected with 2 mg each of the T7 RNA polymerase gene-
containing plasmid and pCAGGS. Following overnight
incubation at 37°C the cells expressing T7 RNA polymer-
ase were trypsinized and overlaid onto the monolayers
containing the CAT plasmid and expressing the F and
HN or F and HA proteins. Following incubation at 37°C
for 7 h, the monolayers were removed from the dishes by
scraping, lysed by freeze-thawing, and clarified by cen-
trifugation at 14,000 rpm in an Eppendorf microcentrifuge
(Brinkmann Instruments Inc., Westbury, NY). The CAT
activity in the cell lysates resulting from fusion of the two
cell populations was assayed as described previously
(Neumann et al., 1987) using [butryl-1-14C]Coenzyme A
(NEN Life Science products, Boston, MA) as the sub-
strate. The CAT activity was quantified using a Beckman
LS 6500 scintillation counter (Beckman Instruments, Ful-
lerton, CA).
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